Delivery Order SPE2DB22D3301-SPE2DB25FY8RN
- Not listed
- The Defense Logistics Agency awarded a $2,106.45 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,503.56 on July 24, 2025, for Zymfentra 120 mg/ml pens (2-packs), with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- This delivery order, valued at $3,007.12 and awarded July 21, 2025, by the Defense Logistics Agency, provides Zymfentra 120 mg/ml pens (2-pack quantity) to support federal medical supply needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be completed by August 11, 2025, at the contractor's facility in...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp under contract number 4568952013, procures Zymfentra 120 mg/ml pen (2-pack) units with a ceiling value of $1,503.56. The contract represents a competitive, non-set-aside award issued under firm fixed price terms, with an ultimate completion date of August 21, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfillment point for...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,768.42 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This firm fixed price contract, which is not set-aside and is scheduled for completion by July 28, 2025, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. The delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.12, is for the supply of ZYMFENTRA 120 MG/ML PEN KITS, a type of pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open competition. This...
- The Defense Logistics Agency awarded a $9,018.43 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8RNDelivery Order
The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/31/25 |